West Pharmaceutical Services (WST) Assets Average (2010 - 2026)

West Pharmaceutical Services has disclosed Assets Average across 17 years of filings, most recently posting $4.1 billion for Q2 2026.

• In Q2 2026, Assets Average rose 8.13% year-over-year to $4.1 billion; the TTM figure through Jun 2026 stood at $4.1 billion (up 8.13% YoY), while the FY2025 annual figure was $4.0 billion, up 5.89% from the prior year.
• Assets Average came in at $4.1 billion for Q2 2026 at West Pharmaceutical Services, down from $4.2 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $4.2 billion in Q1 2026 to a low of $3.3 billion in Q1 2022.
• Average Assets Average over 5 years is $3.7 billion, with a median of $3.7 billion recorded in 2023.
• Year-over-year, Assets Average climbed 19.43% in 2022 and declined 4.08% in 2024.
• Over 5 years, Assets Average stood at $3.5 billion in 2022, then rose by 9.38% to $3.8 billion in 2023, then slipped by 3.5% to $3.7 billion in 2024, then advanced by 14.45% to $4.2 billion in 2025, then declined by 2.26% to $4.1 billion in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $4.1 billion in Q2 2026, $4.2 billion in Q1 2026, and $4.2 billion in Q4 2025.